Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I isotretinoin capsule study in Japanese healthy adult males (dose escalation and food effect)
jRCT2071220075Phase 1Completed
- Sponsor
- Sun Pharma
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of isotretinoin in acne vulgaris (8 arms), sponsored by Sun Pharma. Primary endpoints: Part 1 pharmacokinetics of isotretinoin and metabolites, Part 1 safety and 2 more. Started Nov 2022; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2071220075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220075.